From Startup Verily Life Sciences Link to Full Article: https://blog.verily.com/2019/01/verily-study-watch-receives-fda-510k.html Please visit their site for more information: Verily Life Sciences.com All,Biotechnology,Healthcare News,Startup News 2019-01-19 06:33:26
From Startup Avrobio Link to Full Article: Phase 1/2 study to be led by team at University of California, San Diego, with rights licensed to AVROBIO CAMBRIDGE, Mass., Jan. 18, 2019 (GLOBE NEWSWIRE) — AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”) a Phase 2 clinical-stage gene therapy company, today announced that
From Startup Avrobio Link to Full Article: Analyst and Investor Event to be Webcast on Wednesday, February 6, 2019 at 6:30 p.m. ET CAMBRIDGE, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) — AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced that clinical trial updates
From Startup Anika Therapeutics Link to Full Article: http://ir.anikatherapeutics.com/news-releases/news-release-details/anika-announces-plans-showcase-hyalofast-international-cartilage BEDFORD, Mass.–(BUSINESS WIRE)–Jan. 16, 2019– Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced plans to showcase HYALOFAST, a biodegradable, HA-based cartilage repair scaffold,
From Startup Precision Biosciences Link to Full Article: http://precisionbiosciences.com/precision-biosciences-announces-formation-of-scientific-advisory-board/ DURHAM, North Carolina, USA, January 16, 2019 – Precision BioSciences today announced the formation of its Scientific Advisory Board (SAB) with four key appointments: Kenneth C. Anderson, MD, Hagop Kantarjian, MD, Raymond Schinazi, PhD, DSc, and Cameron Turtle, MBBS, PhD. Drs. Anderson, Kantarjian,
From Startup Synlogic Tx Link to Full Article: –Phase 1 clinical trial to evaluate safety and tolerability of SYNB1020 in healthy volunteers demonstrated safety, clearance and proof of mechanism– – Data from ongoing Phase 1b/2a clinical trial in patients with cirrhosis and elevated ammonia expected mid-2019 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jan.
From Startup Aptinyx Link to Full Article: https://ir.aptinyx.com/news-releases/news-release-details/aptinyx-reports-top-line-results-phase-2-clinical-study-nyx-2925 NYX-2925 did not achieve statistically significant separation from placebo on primary endpoint Meaningful improvements on pain and other endpoints observed in subjects receiving 50 mg dose and in subjects not taking a concomitant analgesic medication NYX-2925 was well-tolerated with no significant adverse
From Startup Brainstorm Cell Therapeutics Link to Full Article: http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=irol-newsArticle&ID=2383056 Dr. Ralph Kern to Provide Update on the Phase 3 Pivotal Trial of Autologous MSC-NTF Cellular Therapy (NurOwn®) in ALS NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in
From Startup BabyScripts Link to Full Article: Babyscripts, Inc., a Washington D.C.-based virtual care platform for managing obstetrics, announced today that Philips has taken a minority position in the company by leading a $6 million round of financing. The round also included participation from investors StartUp Health and NueCura Partners.